What is Bezuclasti used for?

Bezuclasti is being researched for the treatment of systemic mastocytosis and gastrointestinal stromal tumors.

Is Bezuclasti approved for use?

No, the provided data indicates Bezuclasti is still in clinical development phases.

What type of drug is Bezuclasti?

Bezuclasti is classified as a small molecule drug.

Does Bezuclasti treat cancer?

The drug is being studied for its effects on neoplasms, which are tumors.

Can Bezuclasti treat stomach tumors?

Yes, it is being investigated for use in gastrointestinal stromal tumors.

Bezuclastinib | CAS 1616385-51-3 | NVSHVYGIYPBTEZ

Loading compound...

Small molecule

Bezuclasti (also known as Bezuclastiinib) is a small molecule drug currently in clinical development. It is being studied for its potential to treat conditions like systemic mastocytosis, gastrointestinal stromal tumors, and various neoplasms.

Used for

Systemic mastocytosisGastrointestinal stromal tumorsNeoplasms (tumors)

Conditions

Systemic mastocytosisGastrointestinal stromal tumorsNeoplasms

Class

Small molecule

How to take

Bezuclasti is currently in Phase 3 clinical trials and is not yet FDA-approved for general use based on the provided data.

Talk to your doctor

Questions to ask

·Is Bezuclasti a candidate for my condition?
·What phase of clinical trials is Bezuclasti currently in?
·Are there known side effects for Bezuclasti in tumors?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)